期刊文献+

抗高甘油三酯血症中药的研究进展 被引量:7

Research progress on the Chinese herbal of anti-hypertriglyceridemia
原文传递
导出
摘要 随着经济的迅猛发展和人们生活水平的日益提高,高脂血症已经成为不容忽视的问题,其中高甘油三酯血症也是动脉粥样硬化的重要影响因素。目前临床降胆固醇的药物很多,降甘油三酯的药物相对较少;并且降甘油三酯的药物以贝特类和烟酸类药物居多,而中成药较少,文章综述了近年来国内外学者在中草药抗高甘油三酯血症方面的研究进展及相关的作用机制,分析了从天然产物中寻找和发现有价值的药效成份的应用前景,为抗高甘油三酯血症药物的研究与开发提供参考。 Objective:Hyperlipidemia has become an issue which can not be ignored, with the rapid development of economy and peopleh living standards rising, where hypertriglyceridemia is an important factor of atheresclerosis. Therei-e many Clinical lipid-lowering drug, and the ma- jority are cholesterol-lowering drugs, the number of triglycerides-lowering drugs is relatively small; the most of triglyceride-lowering drugs are western medicine. However, Chinese patent drugs are fewer which are only limited to several drugs, such as fibrates and niacin. This paper reviews the research progress, mechanism and the health benefits of Chinese herbal and analyzes the application prospects of discovering valuable pharmacodynamic ingredients from natural products , which provides a reference to the research and development of anti-hypertriglyceridemia drugs.
出处 《中药药理与临床》 CAS CSCD 北大核心 2014年第1期142-146,共5页 Pharmacology and Clinics of Chinese Materia Medica
基金 科技部"重大新药创制"专项-创新药物研究开发技术平台建设-中药药效学及安全性评价(2012ZX09301002-001-026)
关键词 抗高甘油三酯血症药物 中草药 作用机制 Anti-hypertriglyceridemia drug(抗高甘油三酯血症药物) Chinese herbal
  • 相关文献

参考文献64

  • 1Anderson F,Mbatha SZ,Thomson SR.The early management of pancreatitis associated with hypertriglyceridaemia.South African Journal of Surgery,2011;49(2)∶82-84.
  • 2Hokanson JE,Austin MA.Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level:a meta-analysis of population-based prospective studies.Journal of Cardiovascular Risk,1996;3(2)∶213-219.
  • 3Miller M,Stone NJ,Ballantyne C,et al.Triglycerides and cardiovascular disease:a scientific statement from the American Heart Association.Circulation,2011;123(20)∶2292-333.
  • 4《中国居民营养与健康现状》在京公布[J].营养学报,2004,26(6):417-420. 被引量:126
  • 5Rader JI,Calvert RJ,Hathcock JN.Hepatic toxicity of unmodified and time-release preparation of niacin.The American Journal of Medicine,1992;92 (1)∶77-81.
  • 6Alsheikh-Ali AA,Kuvin JT,Karas RH.Risk of adverse events with fibrates.The American Journal of Cardiology,2004;94(7)∶935-938.
  • 7楼锦英.中药降脂研究现状[J].浙江中医学院学报,2002,26(5):79-80. 被引量:31
  • 8王宇辉,周超凡.中药降脂研究进展[J].中国中药杂志,1999,24(3):184-186. 被引量:99
  • 9韩婷,宓鹤鸣.姜黄的化学成分及药理活性研究进展[J].解放军药学学报,2001,17(2):95-97. 被引量:147
  • 10潘国凤,张晓东,朱晓新.姜黄素抗肿瘤作用及其机制研究最新进展[J].中药药理与临床,2007,23(5):247-252. 被引量:17

二级参考文献323

共引文献1314

同被引文献110

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部